Blood Preparation

Global Market Trajectory & Analytics

MCP21370

EXECUTIVE ENGAGEMENTS

POOL

712
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

142
Interactions with Platform & by Email

PARTICIPANTS

28
Unique # Participated

VALIDATIONS

12
Responses Validated*

COMPANIES

33
Responses Validated*
* Login for a full stack data experience

DATE

APR 2021

TABLES

309

PAGES

372

EDITION

5

PRICE

USD 5600

CODE

MCP21370


COMPETITIVE METRICS

COMPANY

D S N T

% *

*Login to Participate & View Data Stacks
View 33 Companies...

SUBMIT
Note: Best viewed in Landscape Mode
  

HIGHLIGHTS & REPORT INDEX

Amid the COVID-19 crisis, the global market for Blood Preparation estimated at US$39.3 Billion in the year 2020, is projected to reach a revised size of US$56.6 Billion by 2027, growing at a CAGR of 5.3% over the analysis period 2020-2027. Whole Blood, one of the segments analyzed in the report, is projected to record a 5.1% CAGR and reach US$25.3 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Blood Components segment is readjusted to a revised 5.4% CAGR for the next 7-year period.
The Blood Preparation market in the U.S. is estimated at US$10.6 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$12.1 Billion by the year 2027 trailing a CAGR of 8.6% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3% and 4.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.8% CAGR.
In the global Blood Derivatives segment, USA, Canada, Japan, China and Europe will drive the 5.3% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$6.2 Billion in the year 2020 will reach a projected size of US$8.9 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$7.7 Billion by the year 2027, while Latin America will expand at a 6.1% CAGR through the analysis period.

SELECT PLAYERS

AstraZeneca plc; Baxter International Inc; Bristol-Myers Squibb Company; GlaxoSmithKline plc; Leo Pharma A/S; Pfizer, Inc; Sanofi; Xiamen Hisunny Chemical Co., LTD

SEGMENTS

» Product (Whole Blood, Blood Components, Blood Derivatives) » Type (Anticoagulants, Platelet Aggregation Inhibitors, Fibrinolytics) » Application (Thrombocytosis, Pulmonary Embolism, Angina Blood Vessel Complications, Renal Impairment, Other Applications)

GEOGRAPHIES

» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » Spain » Russia » and Rest of Europe » Asia-Pacific » Australia » India » South Korea » and Rest of Asia-Pacific » Latin America » Argentina » Brazil » Mexico » and Rest of Latin America » Middle East » Iran » Israel » Saudi Arabia » United Arab Emirates » and Rest of Middle East » and Africa

TABLE OF CONTENTS

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
World Current & Future Analysis for Blood Preparation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Blood Preparation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Blood Preparation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2020 & 2027
World Current & Future Analysis for Whole Blood by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Whole Blood by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Whole Blood by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for Blood Components by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Blood Components by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Blood Components by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for Blood Derivatives by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Blood Derivatives by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Blood Derivatives by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for Renal Impairment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Renal Impairment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Renal Impairment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for Thrombocytosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Thrombocytosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Thrombocytosis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for Pulmonary Embolism by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Pulmonary Embolism by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Pulmonary Embolism by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for Angina Blood Vessel Complications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Angina Blood Vessel Complications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Angina Blood Vessel Complications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for Anticoagulants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Anticoagulants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Anticoagulants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for Platelet Aggregation Inhibitors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Platelet Aggregation Inhibitors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Platelet Aggregation Inhibitors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for Fibrinolytics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Fibrinolytics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Fibrinolytics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
UNITED STATES
USA Current & Future Analysis for Blood Preparation by Product - Whole Blood, Blood Components and Blood Derivatives - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
USA Historic Review for Blood Preparation by Product - Whole Blood, Blood Components and Blood Derivatives Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Blood Preparation by Product - Percentage Breakdown of Value Sales for Whole Blood, Blood Components and Blood Derivatives for the Years 2012, 2020 & 2027
USA Current & Future Analysis for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
USA Historic Review for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Blood Preparation by Application - Percentage Breakdown of Value Sales for Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications for the Years 2012, 2020 & 2027
USA Current & Future Analysis for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
USA Historic Review for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Blood Preparation by Type - Percentage Breakdown of Value Sales for Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics for the Years 2012, 2020 & 2027
REST OF EUROPE
Rest of Europe Current & Future Analysis for Blood Preparation by Product - Whole Blood, Blood Components and Blood Derivatives - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Blood Preparation by Product - Whole Blood, Blood Components and Blood Derivatives Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Blood Preparation by Product - Percentage Breakdown of Value Sales for Whole Blood, Blood Components and Blood Derivatives for the Years 2012, 2020 & 2027
Rest of Europe Current & Future Analysis for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Blood Preparation by Application - Percentage Breakdown of Value Sales for Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications for the Years 2012, 2020 & 2027
Rest of Europe Current & Future Analysis for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Blood Preparation by Type - Percentage Breakdown of Value Sales for Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics for the Years 2012, 2020 & 2027
AUSTRALIA
Australia Current & Future Analysis for Blood Preparation by Product - Whole Blood, Blood Components and Blood Derivatives - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Australia Historic Review for Blood Preparation by Product - Whole Blood, Blood Components and Blood Derivatives Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Australia 15-Year Perspective for Blood Preparation by Product - Percentage Breakdown of Value Sales for Whole Blood, Blood Components and Blood Derivatives for the Years 2012, 2020 & 2027
Australia Current & Future Analysis for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Australia Historic Review for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Australia 15-Year Perspective for Blood Preparation by Application - Percentage Breakdown of Value Sales for Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications for the Years 2012, 2020 & 2027
Australia Current & Future Analysis for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Australia Historic Review for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Australia 15-Year Perspective for Blood Preparation by Type - Percentage Breakdown of Value Sales for Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics for the Years 2012, 2020 & 2027
INDIA
India Current & Future Analysis for Blood Preparation by Product - Whole Blood, Blood Components and Blood Derivatives - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
India Historic Review for Blood Preparation by Product - Whole Blood, Blood Components and Blood Derivatives Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
India 15-Year Perspective for Blood Preparation by Product - Percentage Breakdown of Value Sales for Whole Blood, Blood Components and Blood Derivatives for the Years 2012, 2020 & 2027
India Current & Future Analysis for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
India Historic Review for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
India 15-Year Perspective for Blood Preparation by Application - Percentage Breakdown of Value Sales for Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications for the Years 2012, 2020 & 2027
India Current & Future Analysis for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
India Historic Review for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
India 15-Year Perspective for Blood Preparation by Type - Percentage Breakdown of Value Sales for Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics for the Years 2012, 2020 & 2027
SOUTH KOREA
South Korea Current & Future Analysis for Blood Preparation by Product - Whole Blood, Blood Components and Blood Derivatives - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
South Korea Historic Review for Blood Preparation by Product - Whole Blood, Blood Components and Blood Derivatives Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
South Korea 15-Year Perspective for Blood Preparation by Product - Percentage Breakdown of Value Sales for Whole Blood, Blood Components and Blood Derivatives for the Years 2012, 2020 & 2027
South Korea Current & Future Analysis for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
South Korea Historic Review for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
South Korea 15-Year Perspective for Blood Preparation by Application - Percentage Breakdown of Value Sales for Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications for the Years 2012, 2020 & 2027
South Korea Current & Future Analysis for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
South Korea Historic Review for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
South Korea 15-Year Perspective for Blood Preparation by Type - Percentage Breakdown of Value Sales for Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics for the Years 2012, 2020 & 2027
REST OF ASIA-PACIFIC
Rest of Asia-Pacific Current & Future Analysis for Blood Preparation by Product - Whole Blood, Blood Components and Blood Derivatives - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Asia-Pacific Historic Review for Blood Preparation by Product - Whole Blood, Blood Components and Blood Derivatives Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Asia-Pacific 15-Year Perspective for Blood Preparation by Product - Percentage Breakdown of Value Sales for Whole Blood, Blood Components and Blood Derivatives for the Years 2012, 2020 & 2027
Rest of Asia-Pacific Current & Future Analysis for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Asia-Pacific Historic Review for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Asia-Pacific 15-Year Perspective for Blood Preparation by Application - Percentage Breakdown of Value Sales for Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications for the Years 2012, 2020 & 2027
Rest of Asia-Pacific Current & Future Analysis for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Asia-Pacific Historic Review for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Asia-Pacific 15-Year Perspective for Blood Preparation by Type - Percentage Breakdown of Value Sales for Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics for the Years 2012, 2020 & 2027
ARGENTINA
Argentina Current & Future Analysis for Blood Preparation by Product - Whole Blood, Blood Components and Blood Derivatives - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Argentina Historic Review for Blood Preparation by Product - Whole Blood, Blood Components and Blood Derivatives Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Argentina 15-Year Perspective for Blood Preparation by Product - Percentage Breakdown of Value Sales for Whole Blood, Blood Components and Blood Derivatives for the Years 2012, 2020 & 2027
Argentina Current & Future Analysis for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Argentina Historic Review for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Argentina 15-Year Perspective for Blood Preparation by Application - Percentage Breakdown of Value Sales for Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications for the Years 2012, 2020 & 2027
Argentina Current & Future Analysis for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Argentina Historic Review for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Argentina 15-Year Perspective for Blood Preparation by Type - Percentage Breakdown of Value Sales for Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics for the Years 2012, 2020 & 2027
BRAZIL
Brazil Current & Future Analysis for Blood Preparation by Product - Whole Blood, Blood Components and Blood Derivatives - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Brazil Historic Review for Blood Preparation by Product - Whole Blood, Blood Components and Blood Derivatives Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Brazil 15-Year Perspective for Blood Preparation by Product - Percentage Breakdown of Value Sales for Whole Blood, Blood Components and Blood Derivatives for the Years 2012, 2020 & 2027
Brazil Current & Future Analysis for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Brazil Historic Review for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Brazil 15-Year Perspective for Blood Preparation by Application - Percentage Breakdown of Value Sales for Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications for the Years 2012, 2020 & 2027
Brazil Current & Future Analysis for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Brazil Historic Review for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Brazil 15-Year Perspective for Blood Preparation by Type - Percentage Breakdown of Value Sales for Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics for the Years 2012, 2020 & 2027
MEXICO
Mexico Current & Future Analysis for Blood Preparation by Product - Whole Blood, Blood Components and Blood Derivatives - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Mexico Historic Review for Blood Preparation by Product - Whole Blood, Blood Components and Blood Derivatives Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Mexico 15-Year Perspective for Blood Preparation by Product - Percentage Breakdown of Value Sales for Whole Blood, Blood Components and Blood Derivatives for the Years 2012, 2020 & 2027
Mexico Current & Future Analysis for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Mexico Historic Review for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Mexico 15-Year Perspective for Blood Preparation by Application - Percentage Breakdown of Value Sales for Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications for the Years 2012, 2020 & 2027
Mexico Current & Future Analysis for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Mexico Historic Review for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Mexico 15-Year Perspective for Blood Preparation by Type - Percentage Breakdown of Value Sales for Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics for the Years 2012, 2020 & 2027
REST OF LATIN AMERICA
Rest of Latin America Current & Future Analysis for Blood Preparation by Product - Whole Blood, Blood Components and Blood Derivatives - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Latin America Historic Review for Blood Preparation by Product - Whole Blood, Blood Components and Blood Derivatives Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Latin America 15-Year Perspective for Blood Preparation by Product - Percentage Breakdown of Value Sales for Whole Blood, Blood Components and Blood Derivatives for the Years 2012, 2020 & 2027
Rest of Latin America Current & Future Analysis for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Latin America Historic Review for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Latin America 15-Year Perspective for Blood Preparation by Application - Percentage Breakdown of Value Sales for Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications for the Years 2012, 2020 & 2027
Rest of Latin America Current & Future Analysis for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Latin America Historic Review for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Latin America 15-Year Perspective for Blood Preparation by Type - Percentage Breakdown of Value Sales for Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics for the Years 2012, 2020 & 2027
IRAN
Iran Current & Future Analysis for Blood Preparation by Product - Whole Blood, Blood Components and Blood Derivatives - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Iran Historic Review for Blood Preparation by Product - Whole Blood, Blood Components and Blood Derivatives Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Iran 15-Year Perspective for Blood Preparation by Product - Percentage Breakdown of Value Sales for Whole Blood, Blood Components and Blood Derivatives for the Years 2012, 2020 & 2027
Iran Current & Future Analysis for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Iran Historic Review for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Iran 15-Year Perspective for Blood Preparation by Application - Percentage Breakdown of Value Sales for Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications for the Years 2012, 2020 & 2027
Iran Current & Future Analysis for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Iran Historic Review for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Iran 15-Year Perspective for Blood Preparation by Type - Percentage Breakdown of Value Sales for Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics for the Years 2012, 2020 & 2027
ISRAEL
Israel Current & Future Analysis for Blood Preparation by Product - Whole Blood, Blood Components and Blood Derivatives - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Israel Historic Review for Blood Preparation by Product - Whole Blood, Blood Components and Blood Derivatives Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Israel 15-Year Perspective for Blood Preparation by Product - Percentage Breakdown of Value Sales for Whole Blood, Blood Components and Blood Derivatives for the Years 2012, 2020 & 2027
Israel Current & Future Analysis for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Israel Historic Review for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Israel 15-Year Perspective for Blood Preparation by Application - Percentage Breakdown of Value Sales for Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications for the Years 2012, 2020 & 2027
Israel Current & Future Analysis for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Israel Historic Review for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Israel 15-Year Perspective for Blood Preparation by Type - Percentage Breakdown of Value Sales for Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics for the Years 2012, 2020 & 2027
SAUDI ARABIA
Saudi Arabia Current & Future Analysis for Blood Preparation by Product - Whole Blood, Blood Components and Blood Derivatives - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Saudi Arabia Historic Review for Blood Preparation by Product - Whole Blood, Blood Components and Blood Derivatives Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Saudi Arabia 15-Year Perspective for Blood Preparation by Product - Percentage Breakdown of Value Sales for Whole Blood, Blood Components and Blood Derivatives for the Years 2012, 2020 & 2027
Saudi Arabia Current & Future Analysis for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Saudi Arabia Historic Review for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Saudi Arabia 15-Year Perspective for Blood Preparation by Application - Percentage Breakdown of Value Sales for Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications for the Years 2012, 2020 & 2027
Saudi Arabia Current & Future Analysis for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Saudi Arabia Historic Review for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Saudi Arabia 15-Year Perspective for Blood Preparation by Type - Percentage Breakdown of Value Sales for Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics for the Years 2012, 2020 & 2027
UNITED ARAB EMIRATES
UAE Current & Future Analysis for Blood Preparation by Product - Whole Blood, Blood Components and Blood Derivatives - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
UAE Historic Review for Blood Preparation by Product - Whole Blood, Blood Components and Blood Derivatives Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
UAE 15-Year Perspective for Blood Preparation by Product - Percentage Breakdown of Value Sales for Whole Blood, Blood Components and Blood Derivatives for the Years 2012, 2020 & 2027
UAE Current & Future Analysis for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
UAE Historic Review for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
UAE 15-Year Perspective for Blood Preparation by Application - Percentage Breakdown of Value Sales for Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications for the Years 2012, 2020 & 2027
UAE Current & Future Analysis for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
UAE Historic Review for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
UAE 15-Year Perspective for Blood Preparation by Type - Percentage Breakdown of Value Sales for Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics for the Years 2012, 2020 & 2027
REST OF MIDDLE EAST
Rest of Middle East Current & Future Analysis for Blood Preparation by Product - Whole Blood, Blood Components and Blood Derivatives - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Middle East Historic Review for Blood Preparation by Product - Whole Blood, Blood Components and Blood Derivatives Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Middle East 15-Year Perspective for Blood Preparation by Product - Percentage Breakdown of Value Sales for Whole Blood, Blood Components and Blood Derivatives for the Years 2012, 2020 & 2027
Rest of Middle East Current & Future Analysis for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Middle East Historic Review for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Middle East 15-Year Perspective for Blood Preparation by Application - Percentage Breakdown of Value Sales for Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications for the Years 2012, 2020 & 2027
Rest of Middle East Current & Future Analysis for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Middle East Historic Review for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Middle East 15-Year Perspective for Blood Preparation by Type - Percentage Breakdown of Value Sales for Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics for the Years 2012, 2020 & 2027
AFRICA
Africa Current & Future Analysis for Blood Preparation by Product - Whole Blood, Blood Components and Blood Derivatives - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Africa Historic Review for Blood Preparation by Product - Whole Blood, Blood Components and Blood Derivatives Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Africa 15-Year Perspective for Blood Preparation by Product - Percentage Breakdown of Value Sales for Whole Blood, Blood Components and Blood Derivatives for the Years 2012, 2020 & 2027
Africa Current & Future Analysis for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Africa Historic Review for Blood Preparation by Application - Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Africa 15-Year Perspective for Blood Preparation by Application - Percentage Breakdown of Value Sales for Renal Impairment, Other Applications, Thrombocytosis, Pulmonary Embolism and Angina Blood Vessel Complications for the Years 2012, 2020 & 2027
Africa Current & Future Analysis for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Africa Historic Review for Blood Preparation by Type - Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Africa 15-Year Perspective for Blood Preparation by Type - Percentage Breakdown of Value Sales for Anticoagulants, Platelet Aggregation Inhibitors and Fibrinolytics for the Years 2012, 2020 & 2027
Total Companies Profiled: 33

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com